Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MedPlus Health Services has informed exchanges that its subsidiary, Optival Health Solutions Private Limited, received an order from the Drugs Control Administration in Guntur, Andhra Pradesh, suspending the drug license of a single store located at Chowdarypet, Guntur for three days. The order was issued under Rule 65 of the Drugs and Cosmetics Act, 1940, and was received on August 13, 2025. The estimated financial impact is minimal at around Rs. 0.87 lacs in potential revenue loss. The matter has been disclosed under SEBI Listing Regulations to keep the stock exchanges informed.
This is a very minor compliance event affecting just one store for three days, with a negligible financial impact of under Rs. 1 lakh. It is unlikely to have any meaningful effect on the company's overall business, operations, or stock price.